Safety Evaluation of Oral Care Probiotics Weissella cibaria CMU and CMS1 by Phenotypic and Genotypic Analysis
Source : Int J Mol Sci. 2019;20(11). / SCI / in vitro
Authors : Mi-Sun Kang, Ji-Eun Yeu and Sang-Phil Hong
The safety of oral probiotics, oraCMU and oraCMS1, was evaluated and both probiotics were found to have no safety issues in connection with antibiotic resistance genes and their transferability, hemolysis, mucin degradation, toxin production, platelet aggregation reaction, and such. The oral probiotics, oraCMU(A) and oraCMS(B), did not show hemolysis.
To learn more, visit: pubmed.ncbi.nlm.nih.gov